Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2011-08-01 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANGLET (64600), Pyrenees-Atlantiques
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DE MONTBRUN : revenue, balance sheet and financial ratios
SARL PHARMACIE DE MONTBRUN is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANGLET (64600),
this company of category PME
shows in 2024 a net income positive of 111 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DE MONTBRUN (SIREN 533966958)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
111 222 €
128 697 €
150 961 €
120 837 €
187 701 €
139 523 €
-99 825 €
58 952 €
66 168 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SARL PHARMACIE DE MONTBRUN generates positive net income of 111 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 66 k€ -> 111 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
111 222 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 84%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
84.494%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.146%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DE MONTBRUN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
833.79
610.869
882.224
467.702
267.983
197.846
138.995
103.041
84.494
Financial autonomy
9.874
12.418
8.833
15.775
23.714
29.206
36.383
41.263
47.146
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
84.492024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-8 pts over 3 years
In 2024, the debt ratio of SARL PHARMACIE DE MONTBRUN (84.49) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.15%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+11 pts over 3 years
In 2024, the financial autonomy of SARL PHARMACIE DE MONTBRUN (47.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 61.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
61.562
Liquidity indicators evolution SARL PHARMACIE DE MONTBRUN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
89.528
75.927
83.677
77.261
64.665
65.123
75.822
74.819
61.562
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
61.562024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of SARL PHARMACIE DE MONTBRUN (61.56) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SARL PHARMACIE DE MONTBRUN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SARL PHARMACIE DE MONTBRUN is estimated at
1 552 741 €
(range 1 081 304€ - 2 322 989€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1081k€1552k€2322k€
1 552 741 €Range: 1 081 304€ - 2 322 989€
NAF 5 année 2024
Valuation method used
Net Income Multiple
111 222 €
×
14.0x
=1 552 741 €
Range: 1 081 305€ - 2 322 990€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DE MONTBRUN with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DE MONTBRUN
What is the revenue of SARL PHARMACIE DE MONTBRUN ?
The revenue of SARL PHARMACIE DE MONTBRUN is not publicly disclosed (confidential accounts filed with INPI).
Is SARL PHARMACIE DE MONTBRUN profitable?
Yes, SARL PHARMACIE DE MONTBRUN generated a net profit of 111 k€ in 2024.
Where is the headquarters of SARL PHARMACIE DE MONTBRUN ?
The headquarters of SARL PHARMACIE DE MONTBRUN is located in ANGLET (64600), in the department Pyrenees-Atlantiques.
Where to find the tax return of SARL PHARMACIE DE MONTBRUN ?
The tax return of SARL PHARMACIE DE MONTBRUN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DE MONTBRUN operate?
SARL PHARMACIE DE MONTBRUN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart